Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Cardio3 BioSciences (C3BS), a biotechnology company, has received Good Manufacturing Practice (GMP) Certification for its new production facilities in Mont-Saint-Guibert.
Subscribe to our email newsletter
Certification was granted by the Federal Agency for Medicines and Health Products (FAMHP) in Belgium.
The Mont-St-Guibert production facilities are used in the manufacture and testing of Cardio3 BioSciences’ C3BS-CQR-1, a regenerative therapy currently in development for the treatment of heart failure, the company said.
C3BS CEO Christian Homsy said: "Gaining GMP certification from the health authorities is also a key step for Cardio3 BioSciences ahead of our planned Phase III trial for C3BS-CQR-1, a product we believe offers a potentially revolutionary new approach for the treatment of heart failure, one of the world’s most significant unmet medical needs."